209 related articles for article (PubMed ID: 12065567)
1. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
Schuchter LM; Hensley ML; Meropol NJ; Winer EP;
J Clin Oncol; 2002 Jun; 20(12):2895-903. PubMed ID: 12065567
[No Abstract] [Full Text] [Related]
2. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Hensley ML; Schuchter LM; Lindley C; Meropol NJ; Cohen GI; Broder G; Gradishar WJ; Green DM; Langdon RJ; Mitchell RB; Negrin R; Szatrowski TP; Thigpen JT; Von Hoff D; Wasserman TH; Winer EP; Pfister DG
J Clin Oncol; 1999 Oct; 17(10):3333-55. PubMed ID: 10506637
[TBL] [Abstract][Full Text] [Related]
3. [Development of cancer chemotherapy. Cytoprotective agents].
Lopez M
Clin Ter; 2001; 152(2):135-43. PubMed ID: 11441524
[No Abstract] [Full Text] [Related]
4. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
Hensley ML; Hagerty KL; Kewalramani T; Green DM; Meropol NJ; Wasserman TH; Cohen GI; Emami B; Gradishar WJ; Mitchell RB; Thigpen JT; Trotti A; von Hoff D; Schuchter LM
J Clin Oncol; 2009 Jan; 27(1):127-45. PubMed ID: 19018081
[TBL] [Abstract][Full Text] [Related]
5. Re: Sodium thiosulfate in cisplatin overdose by Erdlenbruch B et al., Med Pediatr Oncol 2002;38:349-352.
Bleyer A; Alberts DS
Med Pediatr Oncol; 2003 Jun; 40(6):413; author reply 414. PubMed ID: 12692822
[No Abstract] [Full Text] [Related]
6. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.
Souid AK; Fahey RC; Aktas MK; Sayin OA; Karjoo S; Newton GL; Sadowitz PD; Dubowy RL; Bernstein ML
Drug Metab Dispos; 2001 Nov; 29(11):1460-6. PubMed ID: 11602522
[TBL] [Abstract][Full Text] [Related]
7. Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy.
Links M; Lewis C
Drugs; 1999 Mar; 57(3):293-308. PubMed ID: 10193684
[TBL] [Abstract][Full Text] [Related]
8. Future development of amifostine as a radioprotectant.
Werner-Wasik M
Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
[TBL] [Abstract][Full Text] [Related]
9. Recent developments and emerging options: the role of amifostine as a broad-spectrum cytoprotective agent.
Capizzi RL
Semin Oncol; 1999 Apr; 26(2 Suppl 7):1-2. PubMed ID: 10348254
[No Abstract] [Full Text] [Related]
10. A review of the use of chemoprotectants in cancer chemotherapy.
Lewis C
Drug Saf; 1994 Sep; 11(3):153-62. PubMed ID: 7811398
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective agents used in the treatment of patients with cancer.
Hogle WP
Semin Oncol Nurs; 2007 Aug; 23(3):213-24. PubMed ID: 17693348
[TBL] [Abstract][Full Text] [Related]
12. Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: a critique.
Hellmann K
J Clin Oncol; 2000 May; 18(9):2004-6. PubMed ID: 10784645
[No Abstract] [Full Text] [Related]
13. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs.
Miller RC; Murley JS; Grdina DJ
Radiat Res; 2014 May; 181(5):464-70. PubMed ID: 24754562
[TBL] [Abstract][Full Text] [Related]
14. [Amifostine as a supporting treatment during cancer therapy].
Jantunen E; Puistola U
Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841
[No Abstract] [Full Text] [Related]
15. [Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the Clinical Use of Cytoprotectives].
Büntzel J; Bokemeyer C; Wagner W;
Onkologie; 2001 Feb; 24(1):81-6. PubMed ID: 11441287
[No Abstract] [Full Text] [Related]
16. WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.
Souid AK; Fahey RC; Dubowy RL; Newton GL; Bernstein ML
Cancer Chemother Pharmacol; 1999; 44(6):498-504. PubMed ID: 10550571
[TBL] [Abstract][Full Text] [Related]
17. Radioprotectants: current status and new directions.
Grdina DJ; Murley JS; Kataoka Y
Oncology; 2002; 63 Suppl 2():2-10. PubMed ID: 12466639
[TBL] [Abstract][Full Text] [Related]
18. Current role of chemotherapy protectors in cancer treatment.
Cáceres W; Báez L; Aponte I; Rodríguez N; Maldonado A
Bol Asoc Med P R; 1997; 89(10-12):184-8. PubMed ID: 9577052
[TBL] [Abstract][Full Text] [Related]
19. Amifostine.
Viele C
Clin J Oncol Nurs; 1999 Jul; 3(3):128, 131. PubMed ID: 10690046
[No Abstract] [Full Text] [Related]
20. The effect of cytoprotective agents in platinum anticancer therapy.
Jakupec MA; Galanski M; Keppler BK
Met Ions Biol Syst; 2004; 42():179-208. PubMed ID: 15206103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
